A review of the latest executive moves in the pharma industry.
Tag Archive for: Sensorium Therapeutics
Sensorium Therapeutics, which closed a $30 million Series A Tuesday, is embracing the complexity of neuropsychiatric diseases with nature-inspired psychoactive medicines.